Invitae Corp (NVTAQ)

Market Cap	974.08K
Revenue (ttm)	481.58M
Net Income (ttm)	-1.44B
Shares Out	275.60M
EPS (ttm)	-5.24
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	104,437
Open	0.0001
Previous Close	0.0034
Day's Range	0.0001 - 0.0015
52-Week Range	n/a
Beta	1.28
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NVTAQ

Invitae Corporation, a medical genetics company, that provides genetic information to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, precision oncology, women's health, rare diseases, and pharmacogenomics; digital health solutions; and health data services. It serves patients, healthcare providers, biopharma companies, and other partners. The company was formerly known as Locus Development, Inc. and changed its name to Invit...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Feb 12, 2015
• Employees: 1,700
• Stock Exchange: OTCMKTS
• Ticker Symbol: NVTAQ

Financial Performance

In 2022, Invitae's revenue was $516.30 million, an increase of 12.13% compared to the previous year's $460.45 million. Losses were -$3.11 billion, 719.6% more than in 2021.